Comparative risk of endophthalmitis after intravitreal injection with bevacizumab, aflibercept, and ranibizumab

Conclusion: The odds of endophthalmitis with aflibercept and ranibizumab combined were higher compared with the sterilely preloaded bevacizumab, arguing for a safety advantage of sterile preloading of anti–vascular endothelial growth factor injections.
Source: RETINA - Category: Opthalmology Tags: Original Study Source Type: research